The comprehensive study was presented on Monday, September 15th, 2025 at the EASD Congress 2025 by Drs R. W. Thomsen,

The research study was presented on Monday, September 15th, 2025 at the EASD Congress 2025 by Drs T. M. Schechter,

The comprehensive study was presented on Monday, September 15th, 2025 at the EASD Congress 2025 by Drs T. Jansk, Dr.

A phase 1 clinical trial presented at the 61st European Association for the Study of Diabetes (EASD) conference in Vienna

A comprehensive analysis from the China Health and Retirement Longitudinal Study has revealed that stronger grip strength is associated with

A pioneering study has demonstrated that machine learning algorithms can accurately predict mortality risk in patients with both heart failure

A new study from the University of Pisa has revealed important differences in how two major classes of diabetes medications

A groundbreaking French study has provided the first comprehensive evidence on using SGLT2 inhibitors in patients with Prader-Willi syndrome who

Researchers have developed a groundbreaking artificial intelligence system called DiabetAid that promises to revolutionize how doctors select personalized treatment combinations

A comprehensive analysis of over 74,000 patients with type 2 diabetes has revealed alarming gaps in adherence to established treatment